Bristol profit could suffer, despite Plavix win
23469
Huge supplies of a generic form of   Bristol-Myers Squibb Co.'s BMY.N best-selling drug in the   market could hurt the company's earnings in 2006 and 2007, even   after a U.S. judge halted new shipments of the copycat drug,   analysts cautioned on Friday.
263446
By NO BYLINE  DELL, the world's second-largest personal computer maker, today warned profits would continue to remain under pressure in the short term after it saw fourth-quarter profit drop to GBP 344 million, from around GBP 516m the year before.
707894
The London stock markets could struggle again next week if the dollar continues its decline, cutting into the profits of British companies that rely heavily on the US economy for business, analysts said.
400668
Heading into the heart of earnings season this week the expected results look robust, but a slowing of future profit growth and the impact of surging oil prices on the economy could conspire to hold down stocks.
178475
Heading into the heart of earnings season next week the expected results look robust, but a slowing of future profit growth and the impact of surging oil prices on the economy could conspire to hold down stocks.
379511
Bristol-Myers Squibb Co on Thursday reported a loss from continuing operations as special charges more than offset strong sales growth of its array of prescription drugs.
591674
Bristol-Myers Squibb (nyse: BMY - news - people ) will report third-quarter earnings. Analysts surveyed by Thomson First Call expect the pharmaceutical maker to earn 39 cents per share compared with 47 cents a year ago.
363785
Sales of the multiple sclerosis drug are picking up, but probably can't grow into the stock's valuation.
569487
Bulging costs keep the drugmaker from showing a profit.
750235
BRISTOL, Tenn. Bristol-based King Pharmaceuticals is reporting a 74 percent drop in third-quarter profits, and says it&#39;s evaluating whether to restate results because of a high level of product returns.
37904
The drug maker's difficulties are evident, but its productivity may make it worth a second look.
269196
Bristol-Myers Squibb Co.  on Monday said it had pleaded guilty to two federal criminal counts related to allegations it had illegally concealed a deal to block introduction of a generic form of its blockbuster Plavix anti-clotting drug.
626092
Should a dreadful first quarter keep you away from this stock?
454567
Bristol-Myers Squibb Co. BMY.N on  Friday said quarterly profit fell 16 percent on special charges  and lower U.S. sales amid competition from rival brands and  cheaper generics.
741856
Canadian drugmaker Apotex Corp. on  Tuesday launched a generic version of Bristol-Myers Squibb  Co.'s  blockbuster Plavix anti-clotting medicine,  threatening Bristol's earnings outlook and dividend.
481445
Bristol-Myers Squibb's   much-criticized chief executive is now out of the picture, but  company earnings prospects remain bleak and the absence of a  permanent new leader could make the drugmaker prey to a  takeover, analysts said on Tuesday.
358404
Schering-Plough Corp  reported on Monday that third-quarter profit and sales rose, but still fell short of estimates, sending shares down 13 percent amid concerns about its flagship cholesterol drugs.